Atherectomy Devices Market Size & Growth Forecast 2027–2036, By Segments (Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Atherectomy Devices Market size was more than USD 1.17 billion in 2026 and is set to grow at a 7.7% CAGR between 2027 and 2036, crossing USD 2.46 billion by 2036. The industry revenue for 2027 is estimated at USD 1.25 billion.
Get more details on this report
Request Free Sample ReportAtherectomy Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 43.99% of the market in 2026, driven by mature cardiovascular care networks, high procedure volumes, and widespread clinician adoption for complex lesion preparation.
- Asia Pacific is forecast to expand at a 9.15% CAGR as access to minimally invasive vascular procedures improves and healthcare providers broaden capabilities for managing complex arterial blockages.
Segment Momentum
- Directional Atherectomy held a 38.05% share in 2026 because it provides controlled plaque removal and fits established treatment workflows for complex peripheral lesions requiring precise vessel preparation.
- Laser Atherectomy is the fastest-growing type as clinicians increasingly adopt it for managing complex calcified, fibrotic, and in-stent lesions that require greater procedural flexibility.
Market Expansion Drivers
- Rising prevalence of coronary and peripheral artery diseases driving procedural demand.
- Increasing adoption of minimally invasive vascular procedures improving clinical outcomes.
- Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions.
Leading Market Participants
- Top companies in the atherectomy devices market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Abbott Laboratories (United States), Koninklijke Philips N.V. (Netherlands), Becton Dickinson and Company (United States), Terumo Corporation (Japan), AngioDynamics Inc. (United States), Cardinal Health Inc. (United States), Avinger Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.17 billion
- 2027 Estimated Market Size: USD 1.25 billion.
- Projected Market Size: USD 2.46 billion by 2036
- Growth Forecast: 7.7% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Directional Atherectomy (Type)
- Emerging Opportunity Segment: Laser Atherectomy (Type)
Market Growth Drivers and Industry Trends
Rising prevalence of coronary and peripheral artery diseases driving procedural demand
Increasing prevalence of coronary and peripheral artery diseases is supporting growth in the atherectomy devices market by expanding the population requiring vascular interventions. Higher procedural requirements are creating greater demand for devices capable of addressing arterial blockages during cardiovascular treatment.
Increasing adoption of minimally invasive vascular procedures improving clinical outcomes
The atherectomy devices market benefits from growing preference for minimally invasive vascular procedures, as clinicians seek treatment approaches that can improve procedural outcomes while limiting the invasiveness associated with conventional interventions. Wider use of these procedures is encouraging integration of atherectomy technologies into vascular treatment strategies.
Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions
Expansion of hybrid cath labs is creating a more capable procedural environment for the atherectomy devices market, combining advanced imaging with cardiovascular intervention capabilities. These facilities support complex, image-guided procedures and provide clinicians with improved infrastructure for performing advanced vascular treatments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of PAD (Peripheral Artery Disease) | 3.10% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Increasing adoption of minimally invasive atherectomy | 2.90% | Medium term (2–5 yrs) | Asia Pacific, North America (spillover: Europe) | Medium | Moderate |
| Advances in directional & orbital atherectomy devices | 2.10% | Long term (5+ yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Slow |
| Rising prevalence of coronary and peripheral artery diseases driving procedural demand | 2.20% | High | North America, Europe, Asia Pacific | High | Near Term |
| Increasing adoption of minimally invasive vascular procedures improving clinical outcomes | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions | 1.60% | Moderate | Europe, North America | Emerging | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The atherectomy devices market was led by North America, which held a 43.99% share in 2026, reflecting the region's sophisticated cardiovascular care infrastructure and established use of minimally invasive vascular procedures. High awareness of peripheral and coronary artery disease, availability of specialized interventional facilities, and growing physician familiarity with plaque-modifying technologies support demand for atherectomy devices. The preference for catheter-based approaches that can improve lesion preparation and facilitate subsequent vascular intervention further contributes to adoption, while ongoing advances in procedural imaging and device technology reinforce the region's established position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing market, driven by improving access to cardiovascular care, expanding hospital infrastructure, and increasing adoption of minimally invasive vascular interventions. Rising awareness of peripheral vascular disease and the need for more effective treatment options are encouraging healthcare providers to strengthen interventional capabilities. Investments in specialized medical facilities, improvements in physician training, and broader availability of advanced cardiovascular technologies are creating a stronger environment for atherectomy procedures across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Vascular CareGermany prioritizes atherectomy technologies that integrate with advanced imaging and evidence-based vascular treatment pathways. Hospitals in Germany focus on device reliability and procedural precision while supporting complex peripheral artery disease management.
France 🇫🇷
Integrated Vascular TreatmentFrance supports atherectomy device adoption within multidisciplinary cardiovascular care programs focused on complex arterial disease. French healthcare institutions increasingly incorporate advanced endovascular technologies that improve treatment flexibility and procedural planning.
Italy 🇮🇹
Specialized Endovascular PracticeItaly continues expanding the use of atherectomy devices in specialized vascular centers treating peripheral artery disease. Clinical teams in Italy prioritize effective plaque removal technologies that complement balloon angioplasty and other minimally invasive interventions.
Japan 🇯🇵
Complex Lesion ManagementJapan continues adopting atherectomy devices for calcified vascular lesions requiring precise endovascular intervention. Clinicians in Japan emphasize device performance, procedural safety, and compatibility with minimally invasive treatment strategies for aging patient populations.
South Korea 🇰🇷
Innovation-Driven ProceduresSouth Korea strengthens atherectomy adoption through modern catheterization laboratories and increasing demand for minimally invasive vascular care. Healthcare providers in South Korea actively evaluate advanced plaque modification technologies that enhance clinical workflow and patient outcomes.
United States 🇺🇸
Advanced Intervention AdoptionThe U.S. atherectomy devices market emphasizes minimally invasive treatment for peripheral and coronary artery disease through technologically advanced plaque removal systems. Healthcare providers in the U.S. continue expanding image-guided procedures and outpatient vascular interventions to improve procedural efficiency.
Segment Leadership and Growth Trends
Atherectomy Devices Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Directional Atherectomy (Largest Segment) vs Laser Atherectomy (Fastest-Growing Segment)
Directional atherectomy dominated the atherectomy devices market with a 38.05% share in 2026, supported by its ability to selectively remove plaque from diseased blood vessels while facilitating restoration of vascular flow. The technique is particularly valuable in interventions where controlled plaque removal and vessel preparation are important to treatment outcomes. Increasing attention to minimally invasive approaches for peripheral vascular disease, together with continued demand for catheter-based interventions, supports the established position of directional atherectomy devices.
Laser atherectomy is the fastest-growing type segment, driven by growing interest in technologies capable of addressing complex and resistant vascular lesions through minimally invasive intervention. Laser-based systems can facilitate plaque modification and lesion treatment in situations where conventional approaches may be challenging. Continued innovation in catheter technologies, increasing physician familiarity with advanced atherectomy techniques, and the broader shift toward less invasive vascular procedures are supporting greater adoption of laser atherectomy.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy | Directional Atherectomy | Laser Atherectomy |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the atherectomy devices market:
1. Boston Scientific Corporation (United States)
2. Medtronic plc (Ireland)
3. Abbott Laboratories (United States)
4. Koninklijke Philips N.V. (Netherlands)
5. Becton Dickinson and Company (United States)
6. Terumo Corporation (Japan)
7. AngioDynamics Inc. (United States)
8. Cardinal Health Inc. (United States)
9. Avinger Inc. (United States)
The atherectomy devices market is advancing through continuous innovation focused on improving cardiovascular treatment outcomes and procedural precision. Device enhancements are increasingly centered on safety, efficiency, and minimally invasive performance. Strong R&D activity is supporting next-generation device development, while collaborative efforts are helping refine clinical usability and expand therapeutic applications.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Abbott Laboratories (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| AngioDynamics Inc. (United States) | |||||||
| Cardinal Health Inc. (United States) | |||||||
| Avinger Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Avinger | Aug-24 | Avinger completed the commercial launch of its Pantheris LV image-guided directional atherectomy system for peripheral artery disease treatment in larger vessels, including the superficial femoral artery. The system features enhanced plaque excision speed and improved catheter control, expanding Avinger’s image-guided atherectomy portfolio and reinforcing its competitive positioning in above-the-knee interventions. |
| Abbott | Apr-23 | Abbott completed the acquisition of Cardiovascular Systems, Inc., a specialist in atherectomy systems used for peripheral and coronary artery disease treatment. The integration adds orbital atherectomy technology to Abbott’s vascular portfolio, strengthening its minimally invasive intervention capabilities and expanding its offering across vessel preparation solutions used in angioplasty and stenting procedures globally. |
| Koninklijke Philips N.V. | Dec-21 | Koninklijke Philips N.V. acquired Vesper Medical Inc., a U.S.-based developer of minimally invasive peripheral vascular devices. The acquisition enhances Philips’ vascular intervention portfolio by incorporating venous stent technologies targeting deep venous disease, strengthening its position in the broader peripheral vascular and minimally invasive treatment market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Atherectomy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Treatment Indication | Peripheral Artery Disease, Coronary Artery Disease, Critical Limb Ischemia, Other Vascular Occlusive Conditions |
| Vascular Territory | Lower Extremity Arteries, Coronary Arteries, Carotid Arteries, Renal Arteries, Other Vascular Territories |
| Procedure Setting | Hospitals, Ambulatory Surgical Centers, Specialty Vascular Centers |
Atherectomy Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Hospital Cath Lab Investment Assessment |
|
| Physician Training and Adoption Landscape |
|
| Reimbursement and Healthcare Economics Review |
|
Need a different cut of the data?
Request Custom ResearchHow big is the atherectomy devices market?
How is the atherectomy devices industry projected to perform over the next decade?
How is the expansion of hybrid cath labs influencing adoption of advanced atherectomy procedures?
Why is the shift toward minimally invasive vascular interventions increasing demand for atherectomy devices?
Why is directional atherectomy the leading type in the atherectomy devices market?
Which atherectomy device type is growing fastest?
What factors support North America's leadership in the atherectomy devices market?
Why is Asia Pacific the fastest-growing region for atherectomy devices?
Who are the major participants shaping the atherectomy devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization